R Pedersen, W Soliman, H Lund-Andersen, M … - Acta Ophthalmologica Scandinavica, 2007 - duanesolution.com Methods: A retrospective observational, uncontrolled case series including 26
eyes in 25 patients followed for up to 6 months after intravitreal injection of
bevacizumab 1 mg repeated as deemed necessary after monthly assessments by ... Cited by 38 - Related articles - Cached - BL Direct - All 5 versions
WM Chan, TYY Lai, DTL Liu, DSC Lam - American Journal of Ophthalmology, 2007 - Elsevier At baseline, the mean logMAR BCVA was 0.48 (Snellen equivalent = 20/60). The
mean logMAR BCVA improved significantly to 0.25 (Snellen equivalent = 20/36) and
0.17 (Snellen equivalent = 20/30) at one and six months, respectively (both ... Cited by 31 - Related articles - All 12 versions
- ►duanesolution.com IA FALKENSTEIN, L Cheng, VL MORRISON, … - Retina, 2007 - journals.lww.com IRYNA A. FALKENSTEIN, MD, LINGYUN CHENG, MD, VICTORIA L. MORRISON, MD, IGOR
KOZAK, MD, AJAY M. TAMMEWAR, MD, WILLIAM R. FREEMAN, MD ... Purpose: To compare
standardized visual outcomes and macular thickness changes associated with ... Cited by 18 - Related articles - BL Direct - All 6 versions
JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ... Cited by 16 - Related articles - All 8 versions
- ►prsjournal.com [PDF] L Arias, N Planas, S Prades, JM Caminal, M … - British Medical Journal, 2008 - bjo.bmj.com Results: There were 17 eyes of 17 patients, and the mean age was 55.4 (SD 10.0)
years. At the 6-month follow-up, the mean visual acuity improved by 8.4 letters
(p = 0.04). Forty-one per cent of patients increased at least one line, and ... Cited by 16 - Related articles - All 5 versions
- ►prsjournal.com RM Silva, JM Ruiz-Moreno, J Nascimento, A … - Retina, 2008 - pdfs.journals.lww.com A significant reduction in ocular coherence tomography central thickness was
observed at 1, 3, and 6 months. No cases of severe visual acuity loss occurred,
and no systemic or ocular side effects were registered during the ... Cited by 13 - Related articles - All 5 versions
S Mandal, P Venkatesh, Z Abbas, R Vohra, S … - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Background To evaluate the efficacy and safety of intra- vitreal
bevacizumab (Avastin) in the treatment of subretinal neovascularization (SRNV)
secondary to type 2A idiopath- ic juxtafoveal telangiectasia (IJT). Methods ... Cited by 12 - Related articles - BL Direct - All 2 versions
A AdAN, C Mateo, R Navarro, E Bitrian, … - Retina, 2007 - journals.lww.com Skip Navigation Links Home > November/December 2007 - Volume 27 - Issue 9 >
Intravitreal Bevacizumab (Avastin) Injection As Primary Trea... ... From the
*Department of Ophthalmology, Hospital Clinic de Barcelona, Universidad de ... Cited by 13 - Related articles - BL Direct - All 4 versions
